Stephen Hall

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Miao J; Jin Y; Marunde R L; Kim S; Quinney S; Radovich M; Li L; Hall S D
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.
Zhang Xin; Quinney Sara K; Gorski J Christopher; Jones David R; Hall Stephen D
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
Wang Zhiping; Kim Seongho; Quinney Sara K; Guo Yingying; Hall Stephen D; Rocha Luis M; Li Lang
Literature mining on pharmacokinetics numerical data: a feasibility study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stephen Hall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Miao J; Jin Y; Marunde R L; Kim S; Quinney S; Radovich M; Li L; Hall S D
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.
The pharmacogenomics journal 2009;9(5):319-26.
2009: Zhang Xin; Quinney Sara K; Gorski J Christopher; Jones David R; Hall Stephen D
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
Drug metabolism and disposition: the biological fate of chemicals 2009;37(8):1587-97.
2009: Wang Zhiping; Kim Seongho; Quinney Sara K; Guo Yingying; Hall Stephen D; Rocha Luis M; Li Lang
Literature mining on pharmacokinetics numerical data: a feasibility study.
Journal of biomedical informatics 2009;42(4):726-35.
2009: Zhou Jihao; Qin Zhaohui; Quinney Sara K; Kim Seongho; Wang Zhiping; Yu Menggang; Chien Jenny Y; Lucksiri Aroonrut; Hall Stephen D; Li Lang
A new probabilistic rule for drug-dug interaction prediction.
Journal of pharmacokinetics and pharmacodynamics 2009;36(1):1-18.
2008: Dennison Jennifer B; Mohutsky Michael A; Barbuch Robert J; Wrighton Steven A; Hall Stephen D
Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes.
The Journal of pharmacology and experimental therapeutics 2008;327(1):248-57.
2008: Malireddy S R; Pinto A G; Chalasani N P; Gorski J C; Hall S D
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report.
Transplantation proceedings 2008;40(5):1789-91.
2008: Dennison Jennifer B; Renbarger Jamie L; Walterhouse David O; Jones David R; Hall Stephen D
Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry.
Therapeutic drug monitoring 2008;30(3):357-64.
2008: Quinney Sara K; Galinsky Raymond E; Jiyamapa-Serna Vanida A; Chen Yong; Hamman Mitchell A; Hall Stephen D; Kimura Robert E
Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats.
Drug metabolism and disposition: the biological fate of chemicals 2008;36(6):1097-101.
2008: Quinney Sara K; Haehner Barbara D; Rhoades Melissa B; Lin Zhen; Gorski J Christopher; Hall Stephen D
Interaction between midazolam and clarithromycin in the elderly.
British journal of clinical pharmacology 2008;65(1):98-109.
2007: Jin Y; Wang Y-H; Miao J; Li L; Kovacs R J; Marunde R; Hamman M A; Phillips S; Hilligoss J; Hall S D
Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.
Clinical pharmacology and therapeutics 2007;82(5):579-85.
2007: Jones David R; Ekins Sean; Li Lang; Hall Stephen D
Computational approaches that predict metabolic intermediate complex formation with CYP3A4 (+b5).
Drug metabolism and disposition: the biological fate of chemicals 2007;35(9):1466-75.
2007: Li Lang; Yu Menggang; Chin Raymond; Lucksiri Aroonrut; Flockhart David A; Hall Stephen D
Drug-drug interaction prediction: a Bayesian meta-analysis approach.
Statistics in medicine 2007;26(20):3700-21.
2007: Dennison Jennifer B; Jones David R; Renbarger Jamie L; Hall Stephen D
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.
The Journal of pharmacology and experimental therapeutics 2007;321(2):553-63.
2007: Kolwankar Dhanashri; Vuppalanchi Raj; Ethell Brian; Jones David R; Wrighton Steven A; Hall Stephen D; Chalasani Naga
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(3):388-93.
2006: Dennison Jennifer B; Kulanthaivel Palaniappan; Barbuch Robert J; Renbarger Jamie L; Ehlhardt William J; Hall Stephen D
Selective metabolism of vincristine in vitro by CYP3A5.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(8):1317-27.
2006: Chien Jenny Y; Lucksiri Aroonrut; Ernest Charles S; Gorski J Christopher; Wrighton Steven A; Hall Stephen D
Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(7):1208-19.
2006: Huang Rong; Murry Daryl J; Kolwankar Dhanashri; Hall Stephen D; Foster David R
Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines.
Biochemical pharmacology 2006;71(12):1695-704.
2006: Lemma Girum L; Wang Zaiqi; Hamman Mitchell A; Zaheer Narjis A; Gorski J Christopher; Hall Stephen D
The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
Clinical pharmacology and therapeutics 2006;79(3):218-30.
2005: Borges Silvana; Li Lang; Hamman Mitchell A; Jones David R; Hall Stephen D; Gorski J Christopher
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(7):1052-5.
2005: Chalasani Naga; Teal Evgenia; Hall Stephen D
Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.
The American journal of gastroenterology 2005;100(6):1317-21.
2005: Gupta Samir K; Eustace Joseph A; Winston Jonathan A; Boydstun Ivy I; Ahuja Tejinder S; Rodriguez Rudolph A; Tashima Karen T; Roland Michelle; Franceschini Nora; Palella Frank J; Lennox Jeffrey L; Klotman Paul E; Nachman Sharon A; Hall Stephen D; Szczech Lynda A
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(11):1559-85.
2005: Liangpunsakul Suthat; Kolwankar Dhanashri; Pinto Amar; Gorski J Christopher; Hall Stephen D; Chalasani Naga
Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
Hepatology (Baltimore, Md.) 2005;41(5):1144-50.
2005: Wang Ying-Hong; Jones David R; Hall Stephen D
Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(5):664-71.
2005: Pinto A G; Horlander J; Chalasani N; Hamman M; Asghar A; Kolwankar D; Hall S D
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.
British journal of clinical pharmacology 2005;59(4):440-6.
2005: Pinto Amar G; Wang Ying-Hong; Chalasani Naga; Skaar Todd; Kolwankar Dhanashri; Gorski J Christopher; Liangpunsakul Suthat; Hamman Mitchell A; Arefayene Million; Hall Stephen D
Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
Clinical pharmacology and therapeutics 2005;77(3):178-88.
2005: Adigun Adegboyega Q; Pinto Amar G; Flockhart David A; Gorski J Christopher; Li Lang; Hall Stephen D; Chalasani Naga
Effect of cirrhosis and liver transplantation on the gender difference in QT interval.
The American journal of cardiology 2005;95(5):691-4.
2005: Ho Herbert; Pinto Amar; Hall Stephen D; Flockhart David A; Li Lang; Skaar Todd C; Cadman Peter; O'Connor Daniel T; Wagner Urban; Fineberg Naomi S; Weinberger Myron H
Association between the CYP3A5 genotype and blood pressure.
Hypertension 2005;45(2):294-8.
2005: Ernest C Steven; Hall Stephen D; Jones David R
Mechanism-based inactivation of CYP3A by HIV protease inhibitors.
The Journal of pharmacology and experimental therapeutics 2005;312(2):583-91.
2004: Uhing Michael R; Beno David W A; Jiyamapa-Serna Vanida A; Chen Yong; Galinsky Raymond E; Hall Stephen D; Kimura Robert E
The effect of anesthesia and surgery on CYP3A activity in rats.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(11):1325-30.
2004: Chalasani Naga; Aljadhey Hisham; Kesterson Joe; Murray Michael D; Hall Stephen D
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.
Gastroenterology 2004;126(5):1287-92.
2004: Wang Ying-Hong; Jones David R; Hall Stephen D
Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(2):259-66.
2004: Gorski J Christopher; Huang Shiew-Mei; Pinto Amar; Hamman Mitchell A; Hilligoss Janna K; Zaheer Narjis A; Desai Mehul; Miller Margaret; Hall Stephen D
The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Clinical pharmacology and therapeutics 2004;75(1):89-100.
2003: Hall Stephen D; Wang Zaiqi; Huang Shiew-Mei; Hamman Mitchell A; Vasavada Nina; Adigun Adegboyega Q; Hilligoss Janna K; Miller Margaret; Gorski J Christopher
The interaction between St John's wort and an oral contraceptive.
Clinical pharmacology and therapeutics 2003;74(6):525-35.
2003: Gorski J Christopher; Vannaprasaht Suda; Hamman Mitchell A; Ambrosius Walter T; Bruce Melissa A; Haehner-Daniels Barbara; Hall Stephen D
The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Clinical pharmacology and therapeutics 2003;74(3):275-87.
2003: Ward Bryan A; Gorski J Christopher; Jones David R; Hall Stephen D; Flockhart David A; Desta Zeruesenay
The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity.
The Journal of pharmacology and experimental therapeutics 2003;306(1):287-300.
2003: Chalasani Naga; Gorski J Christopher; Asghar Maleeha S; Asghar Ali; Foresman Brian; Hall Stephen D; Crabb David W
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2003;37(3):544-50.
2003: Wang Zaiqi; Hall Stephen D; Maya Juan F; Li Lang; Asghar Ali; Gorski J C
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
British journal of clinical pharmacology 2003;55(1):77-85.
2002: Williams J Andrew; Ring Barbara J; Cantrell Varon E; Campanale Kristina; Jones David R; Hall Stephen D; Wrighton Steven A
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(11):1266-73.
2002: Zhao Xue-Jun; Jones D R; Wang Ying-Hong; Grimm S W; Hall S D
Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites.
Xenobiotica; the fate of foreign compounds in biological systems 2002;32(10):863-78.
2002: Williams J Andrew; Ring Barbara J; Cantrell Varon E; Jones David R; Eckstein James; Ruterbories Kenneth; Hamman Mitchell A; Hall Stephen D; Wrighton Steven A
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(8):883-91.
2002: Wang Zaiqi; Hamman Mitchell A; Huang Shiew-Mei; Lesko Lawrence J; Hall Stephen D
Effect of St John's wort on the pharmacokinetics of fexofenadine.
Clinical pharmacology and therapeutics 2002;71(6):414-20.
2002: Shaw Andrew A; Hall Stephen D; Franklin Michael R; Galinsky Raymond E
The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(2):177-82.
2002: Belle Donna J; Callaghan John T; Gorski J Christopher; Maya Juan F; Mousa Omiema; Wrighton Steven A; Hall Stephen D
The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity.
British journal of clinical pharmacology 2002;53(1):67-74.
2002: Asghar Ali; Gorski J Christopher; Haehner-Daniels Barbara; Hall Stephen D
Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(1):20-6.
2001: Chalasani N; Gorski J C; Patel N H; Hall S D; Galinsky R E
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
Hepatology (Baltimore, Md.) 2001;34(6):1103-8.
2001: Wang Z; Gorski J C; Hamman M A; Huang S M; Lesko L J; Hall S D
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Clinical pharmacology and therapeutics 2001;70(4):317-26.
2001: Bruce M A; Hall S D; Haehner-Daniels B D; Gorski J C
In vivo effect of clarithromycin on multiple cytochrome P450s.
Drug metabolism and disposition: the biological fate of chemicals 2001;29(7):1023-8.
2001: Hamman M A; Bruce M A; Haehner-Daniels B D; Hall S D
The effect of rifampin administration on the disposition of fexofenadine.
Clinical pharmacology and therapeutics 2001;69(3):114-21.
2000: Gorski J C; Wang Z; Haehner-Daniels B D; Wrighton S A; Hall S D
The effect of hormone replacement therapy on CYP3A activity.
Clinical pharmacology and therapeutics 2000;68(4):412-7.
2000: Masica A L; Azie N E; Brater D C; Hall S D; Jones D R
Intravenous diltiazem and CYP3A-mediated metabolism.
British journal of clinical pharmacology 2000;50(3):273-6.
2000: Mayhew B S; Jones D R; Hall S D
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(9):1031-7.
2000: Hamman M A; Haehner-Daniels B D; Wrighton S A; Rettie A E; Hall S D
Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.
Biochemical pharmacology 2000;60(1):7-17.
2000: Mousa O; Brater D C; Sunblad K J; Hall S D
The interaction of diltiazem with simvastatin.
Clinical pharmacology and therapeutics 2000;67(3):267-74.
2000: Gorski J C; Hall S D; Becker P; Affrime M B; Cutler D L; Haehner-Daniels B
In vivo effects of interleukin-10 on human cytochrome P450 activity.
Clinical pharmacology and therapeutics 2000;67(1):32-43.
1999: Grubb N G; Rudy D W; Brater D C; Hall S D
Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.
British journal of clinical pharmacology 1999;48(4):494-500.
1999: Gorski J C; Jones D R; Hamman M A; Wrighton S A; Hall S D
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.
Xenobiotica; the fate of foreign compounds in biological systems 1999;29(9):931-44.
1999: Jones D R; Gorski J C; Hamman M A; Mayhew B S; Rider S; Hall S D
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
The Journal of pharmacology and experimental therapeutics 1999;290(3):1116-25.
1999: Hall S D; Thummel K E; Watkins P B; Lown K S; Benet L Z; Paine M F; Mayo R R; Turgeon D K; Bailey D G; Fontana R J; Wrighton S A
Molecular and physical mechanisms of first-pass extraction.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(2):161-6.
1998: Ekins S; Ring B J; Binkley S N; Hall S D; Wrighton S A
Autoactivation and activation of the cytochrome P450s.
International journal of clinical pharmacology and therapeutics 1998;36(12):642-51.
1998: Azie N E; Brater D C; Becker P A; Jones D R; Hall S D
The interaction of diltiazem with lovastatin and pravastatin.
Clinical pharmacology and therapeutics 1998;64(4):369-77.
1998: Gorski J C; Jones D R; Haehner-Daniels B D; Hamman M A; O'Mara E M; Hall S D
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
Clinical pharmacology and therapeutics 1998;64(2):133-43.
1998: Mäenpää J; Hall S D; Ring B J; Strom S C; Wrighton S A
Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
Pharmacogenetics 1998;8(2):137-55.
1998: Rudy A C; Liu Y; Brater C; Hall S D
Stereoselective pharmacokinetics and inversion of (R)- ketoprofen in healthy volunteers.
Journal of clinical pharmacology 1998;38(2 Suppl):3S-10S.
1997: Li A P; Reith M K; Rasmussen A; Gorski J C; Hall S D; Xu L; Kaminski D L; Cheng L K
Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
Chemico-biological interactions 1997;107(1-2):17-30.
1997: Hamman M A; Thompson G A; Hall S D
Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.
Biochemical pharmacology 1997;54(1):33-41.
1997: Gorski J C; Jones D R; Wrighton S A; Hall S D
Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.
Xenobiotica; the fate of foreign compounds in biological systems 1997;27(3):243-56.
1996: Jones D R; Gorski J C; Haehner B D; O'Mara E M; Hall S D
Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
Clinical pharmacology and therapeutics 1996;60(4):374-84.
1996: Haehner B D; Gorski J C; Vandenbranden M; Wrighton S A; Janardan S K; Watkins P B; Hall S D
Bimodal distribution of renal cytochrome P450 3A activity in humans.
Molecular pharmacology 1996;50(1):52-9.
1996: Grubb N G; Rudy D W; Hall S D
Stereoselective high-performance liquid chromatographic analysis of ketoprofen and its acyl glucuronides in chronic renal insufficiency.
Journal of chromatography. B, Biomedical applications 1996;678(2):237-44.
1996: Jones D R; Gorski J C; Hamman M A; Hall S D
Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity.
Journal of chromatography. B, Biomedical applications 1996;678(1):105-11.
1995: Murray M D; Black P K; Kuzmik D D; Haag K M; Manatunga A K; Mullin M A; Hall S D; Brater D C
Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients.
The American journal of the medical sciences 1995;310(5):188-97.
1995: Oian X; Hall S D
Enantioselective effects of experimental diabetes mellitus on the metabolism of ibuprofen.
The Journal of pharmacology and experimental therapeutics 1995;274(3):1192-8.
1995: Rudy A C; Knight P M; Brater D C; Hall S D
Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment.
The Journal of pharmacology and experimental therapeutics 1995;273(1):88-93.
1994: Hall S D; Hamman M A; Rettie A E; Wienkers L C; Trager W F; Vandenbranden M; Wrighton S A
Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1994;22(6):975-8.
1994: Gorski J C; Jones D R; Wrighton S A; Hall S D
Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Biochemical pharmacology 1994;48(1):173-82.
1994: Gorski J C; Hall S D; Jones D R; VandenBranden M; Wrighton S A
Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.
Biochemical pharmacology 1994;47(9):1643-53.
1994: Hall S D; Quan X
The role of coenzyme A in the biotransformation of 2-arylpropionic acids.
Chemico-biological interactions 1994;90(3):235-51.
1994: Rudy A C; Figueroa N L; Hall S D; Brater D C
The pharmacokinetics of piroxicam in elderly persons with and without renal impairment.
British journal of clinical pharmacology 1994;37(1):1-5.
1993: Xiaotao Q; Hall S D
Modulation of enantioselective metabolism and inversion of ibuprofen by xenobiotics in isolated rat hepatocytes.
The Journal of pharmacology and experimental therapeutics 1993;266(2):845-51.
1993: Hall S D; Rudy A C; Knight P M; Brater D C
Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans.
Clinical pharmacology and therapeutics 1993;53(4):393-400.
1993: Tracy T S; Wirthwein D P; Hall S D
Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A.
Drug metabolism and disposition: the biological fate of chemicals 1993;21(1):114-20.
1992: Rudy A C; Bradley J D; Ryan S I; Kalasinski L A; Xiaotao Q; Hall S D
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patients.
Therapeutic drug monitoring 1992;14(6):464-70.
1992: Murray M D; Greene P K; Brater D C; Manatunga A K; Hall S D
Effects of flurbiprofen on renal function in patients with moderate renal insufficiency.
British journal of clinical pharmacology 1992;33(4):385-93.
1992: Knadler M P; Brater D C; Hall S D
Stereoselective disposition of flurbiprofen in uraemic patients.
British journal of clinical pharmacology 1992;33(4):377-83.
1992: Knadler M P; Brater D C; Hall S D
Stereoselective disposition of flurbiprofen in normal volunteers.
British journal of clinical pharmacology 1992;33(4):369-75.
1992: Tracy T S; Hall S D
Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(2):322-7.
1992: Bradley J D; Rudy A C; Katz B P; Ryan S I; Kalasinski L A; Brater D C; Hall S D; Brandt K D
Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis.
The Journal of rheumatology 1992;19(1):130-4.
1992: Griffiths D A; Hall S D; Sokol P P
Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
The Journal of pharmacology and experimental therapeutics 1992;260(1):128-33.
1992: Tracy T S; Krohn K; Jones D R; Bradley J D; Hall S D; Brater D C
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis.
European journal of clinical pharmacology 1992;42(2):121-5.
1992: Hall S D; Hassanzadeh-Khayyat M; Knadler M P; Mayer P R
Pulmonary inversion of 2-arylpropionic acids: influence of protein binding.
Chirality 1992;4(6):349-52.
1991: Rudy A C; Knight P M; Brater D C; Hall S D
Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofen.
The Journal of pharmacology and experimental therapeutics 1991;259(3):1133-9.
1991: Tracy T S; Hall S D
Determination of the epimeric composition of ibuprofenyl-CoA.
Analytical biochemistry 1991;195(1):24-9.
1991: Griffiths D A; Hall S D; Sokol P P
Interaction of 3'-azido-3'-deoxythymidine with organic ion transport in rat renal basolateral membrane vesicles.
The Journal of pharmacology and experimental therapeutics 1991;257(1):149-55.
1991: Fredrick M J; Pound D C; Hall S D; Brater D C
Furosemide absorption in patients with cirrhosis.
Clinical pharmacology and therapeutics 1991;49(3):241-7.
1991: Knadler M P; Hall S D
Stereoselective hydrolysis of flurbiprofen conjugates.
Drug metabolism and disposition: the biological fate of chemicals 1991;19(1):280-2.
1990: Rudy A C; Anliker K S; Hall S D
High-performance liquid chromatographic determination of the stereoisomeric metabolites of ibuprofen.
Journal of chromatography 1990;528(2):395-405.
1990: Knadler M P; Hall S D
Stereoselective arylpropionyl-CoA thioester formation in vitro.
Chirality 1990;2(2):67-73.
1989: Knadler M P; Hall S D
High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urine.
Journal of chromatography 1989;494():173-82.
1989: Knadler M P; Brater D C; Hall S D
Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
The Journal of pharmacology and experimental therapeutics 1989;249(2):378-85.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Stephen Hall

Research Profile (preview)

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Stephen Hall (preview)

All Publications